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Abstract
Background: Alpha-dystroglycan (a-DG) is a cell surface receptor providing a molecular link between the extracellular
matrix (ECM) and the actin-based cytoskeleton. During its biosynthesis, a-DG undergoes specific and unusual O-
glycosylation crucial for its function as a high-affinity cellular receptor for ECM proteins.
Methodology/Principal Findings: We report that expression of functionally glycosylated a-DG during thymic development
is tightly regulated in developing T cells and largely confined to CD42CD82 double negative (DN) thymocytes. Ablation of
DG in T cells had no effect on proliferation, migration or effector function but did reduce the size of the thymus due to a
significant loss in absolute numbers of thymocytes. While numbers of DN thymocytes appeared normal, a marked reduction
in CD4+CD8+ double positive (DP) thymocytes occurred. In the periphery mature naı¨ve T cells deficient in DG showed both
normal proliferation in response to allogeneic cells and normal migration, effector and memory T cell function when tested
in acute infection of mice with either lymphocytic choriomeningitis virus (LCMV) or influenza virus.
Conclusions/Significance: Our study demonstrates that DG function is modulated by glycosylation during T cell
development in vivo and that DG is essential for normal development and differentiation of T cells.
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Introduction
Alpha-dystroglycan (a-DG) is an important cell surface receptor
with high affinity for the extracellular matrix (ECM) proteins
laminin, agrin, perlecan, and neurexin [1] and serves as a cellular
receptor for several arenavirises, including lymphocytic chorio-
meningitis virus (LCMV) and the pathogenic Lassa virus (Cao et
al., 1998). DG is encoded as a single polypeptide chain that is
cleaved into the extracellular a-DG and membrane anchored b-
DG which provides an essential molecular link between ECM and
the actin-based cytoskeleton [2,3]. A remarkable feature of a-DG
is its complex pattern of post-translational modifications, including
unusual sugar modifications, which are crucial for binding to
ECM proteins, such as laminins, perlecan, and neurexins [1].
While the core protein of DG is ubiquitously expressed, functional
glycosylation of a-DG is regulated both in the developing and
adult organism. The genes of the known and putative glycosyl-
transferases POMT1/2, POMGnT1, LARGE1, LARGE2, fuku-
tin and FKRP, which are involved in a-DG modification are
affected in human congenital neuromuscular diseases, so-called
‘‘secondary dystroglycanopathies’’, that manifest in a range of
muscular and brain abnormalities caused by a loss of function of
DG as an ECM receptor [1,4,5]. While the function of DG in
muscle, brain, and other organs becomes increasingly clear, the
role of this important ECM receptor in the immune system is
largely unknown. Significant levels of DG core protein without
detectable functional glycosylation are found in non-adherent cell
types like resting blood lymphocytes [6]. The core protein of a-DG
was found up-regulated after T cell activation and clustered at the
immunological synapse (IS) formed between T cells and antigen-
presenting cells in vitro, suggesting a function for a-DG in T cells
[7] although its role in vivo was unclear. In vivo, the extent of
functional glycosylation, which is crucial for a-DG’s interaction
with all known ligands has been examined in dendritic cells [8,9],
but not yet in T cells. In our present study we sought to close this
gap by addressing the expression of functionally glycosylated a-
DG during T cell development and investigating the function of
DG in developing and mature T cells in vivo.
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Unlike the majority of other hematopoietic cell lineages that
mature in the bone marrow, T cell progenitors leave the bone
marrow and migrate through the blood stream to another primary
lymphatic organ, the thymus, for further development [10,11,12].
Once in the thymus, T cell progenitors proceed through a series of
stages of cell proliferation and differentiation that are tightly
controlled at multiple checkpoints associated with differential gene
expression and regulation [13,14]. Early CD42CD82 double
negative (DN) thymocytes undergo a complex pattern of migration
and differentiation characterized by sequential changes in
expression of the cell surface markers CD25 and CD44 through
the stages DN1 (CD252CD44+), DN2 (CD25+CD44+), DN3
(CD25+CD442), and DN4 (CD252CD442). At the DN3 stage,
successful rearrangement of T cell receptor (TCR) b subunit genes
results in formation of a pre-TCR complex that induces ligand-
independent activation signals for thymocyte survival, prolifera-
tion, and differentiation into CD4+CD8+ double positive (DP)
thymocytes, a process known as b-selection [10,11,12,15]).
The migration and differentiation of T cell progenitors in the
thymus is highly regulated and critically depends on the
interaction of thymocytes with ECM and other cell types including
thymic stromal cells and/or dendritic cells. ECM associated with
thymic epithelial cells (TEC) of the subcapsular region where DN3
cells undergo b-selection is rich in laminin isoforms containing the
laminin a2 chain (laminin-2/4) or the a5 chain (laminin-10/11)
[16,17] that undergo high affinity interactions with a-DG. The
presence of these a-DG ligands in thymic ECM suggests that cell-
matrix interactions mediated by DG may play a role in T cell
survival and/or differentiation.
In the present study, we examined the expression of functionally
glycosylated a-DG during T cell development and investigated the
function of DG in developing and mature T cells in vivo. To
address the role of a-DG in T cells in vivo, we conditionally deleted
the DG core protein in developing thymocytes using Cre-loxP
methodology. Ablation of DG in T cells resulted in reduced size of
the thymus due to a significant reduction in absolute number of
thymocytes. While numbers of DN thymocytes appeared normal,
a marked reduction in DP thymocytes was observed, accompanied
with a significant increase of apoptosis in the thymus. Remarkably,
mature naı¨ve T cells deficient in DG showed normal migration
pattern and effector function when challenged with either LCMV,
or influenza virus as well as a normal proliferative response to
allogeneic stimulation.
Results
Functionally Glycosylated a-DG is Differentially Expressed
During T Cell Development
To assess the biological role of a-DG in T cell development,
we first examined the expression of functionally glycosylated a-
DG on different subsets of thymocytes based on their expression
of CD4 and CD8. Using a monoclonal antibody IIH6
specifically recognizing functionally glycosylated a-DG [18],
high levels of glycosylated a-DG were detected in DN
thymocytes, whereas by contrast only low levels were found
on DP and both CD4+ and CD8+ single positive (SP)
thymocytes (Fig. 1A, top). After sorting of DN thymocytes into
the subpopulations DN1 through DN4 using the markers CD25
and CD44, we observed a significant increase of functionally
glycosylated a-DG in cells progressing from DN1 to DN2
(Fig. 1A). High levels or functionally glycosylated a-DG were
maintained throughout DN3 with a subsequent reduction in
DN4 thymocytes (mean fluorescent intensity decreased 2–4
fold). To demonstrate the ECM binding activity of a-DG
derived from different thymocyte populations, binding to
laminin was assessed by overlay assay. Consistent with our flow
cytometric analysis, laminin binding was detected to a-DG from
DN2 through DN4 stages but not to DP and single positive
thymocytes (Fig. 1B, top). Detection of DG core protein by
immunoblot for b-DG revealed an increase in DG core protein
expression from DN1 through DN3 and remained high in DN4,
DP, CD4 and CD8 single positive cells (Fig. 1B), as well as
mature splenic lymphocytes (Fig. S1). Together, the data
indicate that the levels of functional a-DG during T cell
development are highly regulated primarily at the level of post-
translational modifications.
In order to further investigate the basis for the differential
glycosylation of a-DG during T cell development, we assessed the
expression levels of the known and putative glycosyltransferases
POMT1/2, POMGnT1, LARGE1/2, fukutin and FKRP that are
implicated in a-DG modification, using real-time quantitative
PCR. Among the candidate glycosyltransferases tested, POMT1,
LARGE1, and LARGE2 were subject to changes in expression
during T cell development (Fig. 1C). Of particular interest is the
marked induction of gene expression for POMT1 during the
stages DN2 through DN4, which correlated with the increase in
functional glycosylation of a-DG on T cell precursors (Fig. 1A, B).
Interestingly, only mild changes in transcription of DG core
protein, POMT2, POMGnT1, fukutin, and FKRP were observed
in stages DN1 through DN4 (data not shown), suggesting
differential regulation of the enzymes involved in a-DG glycosyl-
ation during T cell development.
The Ablation of DG in T Cells Leads to Reduced T Cell
Numbers in the Thymus and Periphery
To investigate the roles of a-DG in T cell development and in
mature T cells in vivo, T cell specific DG-deficient mice (DG/Lck-
cre) were generated by crossing DG-floxed mice (DGf/f) with Lck-
cre transgenic mice, an extensively used model to delete the floxed
gene during T cell development [19]. The excision of floxed DG
by the expression of cre recombinase in T cells was monitored by
PCR on genomic DNA isolated from thymocytes and peripheral T
cells (Fig. 2A). In line with the studies by others [19,20], expression
of Cre recombinase under the control of the Lck promoter resulted
in specific recombination of the floxed DG gene in T cells, but
neither B cells nor dendritic cells (Fig. 2A). The specific deletion of
DG protein in splenic T cells and thymocytes were also verified by
immunoblotting with an anti-b-DG antibody (Fig. 2B). As
expected, ablation of the DG gene resulted in a marked reduction
of a-DG in DN thymocytes (Fig. 2C). The levels of a-DG were
significantly reduced in DN2 thymocytes, with a pronounced
decrease in DN3, and undetectable levels in DN4 thymocytes
(Fig. 2D). This result is in accordance with the progression of
excision of the floxed DG allele during T cell development (Fig.
S2). The marked reduction of functional a-DG in DG/Lck-cre
mice on thymocytes during the crucial DN3 and DN4 stage,
allowed us to use this model to address the role of DG in critical
phases of early thymic T cell development, in particular at the first
check point, b-selection.
Next, we characterized the thymic morphology at 6–8 wks after
birth in DG/Lck-cre mice compared to littermate DGf/f controls.
Gross examination of thymi revealed a reduction in overall size
and mass of the organ in DG/Lck-cre mice when compared to the
littermate control (Fig. 3A). Histological analysis of the thymic
architecture by hematoxylin and eosin (H&E) staining revealed
marked hypoplasia in the thymic medulla of DG/Lck-cre mice
(Fig. 3B). The absolute number of total thymocytes was reduced
consistently by 50–70% in DG/Lck-cre mice (Fig. 3C, middle).
Dystroglycan in T Cells
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Analysis of subgroups of thymocytes in DG/Lck-cre mice revealed
a marked reduction in numbers of DP thymocytes with a
concomitant decrease of CD4 and CD8 SP thymocytes (Fig. 3C,
middle and right). In contrast, the numbers of total DN
thymocytes did not significantly change. To exclude possible
effects of Lck promoter driven Cre transgene on T cell
development, Lck-cre mice were included as an additional control.
The numbers of total thymocytes and the numbers of each
thymocyte subset in Lck-cre mice were similar to the numbers
observed in DGf/f mice, excluding an adverse effect of the cre
transgene expression on T cell development in our system (Fig.
S3). When we further dissected the different DN populations, a
moderate increase in the proportion and absolute numbers of
DN3 thymocytes was found in DG/Lck-cre mice (Fig. 3D).
Additionally, we observed about 50–70% reduction of CD4+ and
CD8+ T cells in blood, spleen, and lymph nodes in DG/Lck-cre
mice (Fig. 3E), indicating that the defects in T cell development
lead to the reduced T cell numbers in the periphery. However, the
relative proportion of the TCR Vb repertoire appeared compa-
rable between the DG/Lck-cre mice and controls (Fig. S4).
Increased Apoptosis in the Thymus of DG/Lck-cre Mice
To gain insights into the mechanisms underlying the impact of
DG ablation in T cells, we first examined the proliferation of
thymocytes in DG/Lck-cre mice. We injected mice with
bromodeoxyuridine (BrdU) and harvested thymocytes 2 h later
to analyze the incorporation of BrdU in DG/Lck-cre mice and
littermate controls. The combination of anti-BrdU antibody and
7-amino-actinomycin (7-AAD) in flow cytometric analysis allows
the discrimination between cell populations undergoing cell cycle
progression or apoptosis. The percentage of BrdU incorporation
in DN3, DN4, and DP cells were comparable between DG/Lck-
cre and control mice (Fig. 4A), suggesting that proliferation (S
phase) was not significantly impaired in the absence of DG.
Interestingly, apoptosis (sub-G1 phase) in DN4 thymocytes of
DG/Lck-cre was two to three fold higher than of controls.
However, no significant apoptosis in DP thymocytes could be
detected in this assay due to their high turnover rate [21]. Next we
employed Annexin V staining to determine whether increased
apoptosis accounts for the reduced thymocyte numbers in DG/
Lck-cre mice. Indeed, significantly higher incidence of apoptosis
Figure 1. Differential Expression of Functionally Glycosylated a-DG During T Cell Development. (A) Thymi were harvested from 6- to 8-
week-old C57BL/6 mice. Whole thymocyte suspensions were stained with lineage antibody cocktail (Lin, CD19/NK1.1/CD11c/TCRcd), CD4, CD8, and
IIH6 (for glycosylated a-DG). Lin2 cells were gated and defined the major thymocyte subsets by CD4 and CD8 as DN (CD42CD82), DP (CD4+CD8+),
CD4+, and CD8+ T cells (left). DN lymphocytes were further segregated into various subpopulations as CD44+CD252 DN1, CD44+CD25+ DN2,
CD442CD25+ DN3, and CD442CD252 DN4. Glycosylated a-DG was detected with monoclonal antibody IIH6 (right). The data represented are from at
least three independent experiments. Bold line, anti-glycosylated a-DG; shaded area, unstained. (B) Thymocytes were sorted into various subsets as
indicated and lysed as described in Experimental Procedures. The protein extracts were subjected to SDS-PAGE followed by laminin binding (laminin)
or by immunoblotting for b-DG (core DG protein) and b-actin (loading control) expression. (C) Detection of the messages for POMT1, LARGE1,
LARGE2 by quantitative RT-qPCR: Complementary DNA (cDNA) was synthesized from total RNA of each of the cell types studied. For each cell type,
POMT1, LARGE1, LARGE2 and Rps29 (normalization control) were specifically amplified, in triplicate, in the presence of SYBR green. The expression of
POMT1, LARGE1 and LARGE2 are shown relative to that of the Rps29 in the same sample.
doi:10.1371/journal.pone.0009915.g001
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(Annexin V positive cells) was detected in CD4 and CD8 SP
thymocytes (Fig. 4B) but not in DP thymocytes likely due to their
rapid turnover. These studies were complemented by in situ
TUNEL staining to detect apoptosis in thymic tissue sections.
Consistent with our findings with Annexin V staining, an overall
increase in apoptotic cells was found in the thymus of DG/Lck-cre
mice (Fig. 4C). Together, our data suggest that functional DG on
thymocytes is not required for proliferation but is involved in
survival during T cell development.
DG/Lck-cre Mice In Vivo Exhibit Normal T Cell
Proliferation Following Allogeneic Stimulation and
Normal T Cell Functions During Either Acute LCMV or
Influenza Virus Infections
Others reported a role of a-DG in mature activated T cells as a
receptor for agrin at the immunological synapse in vitro [7,22].
Since our DG/Lck-cre mice showed complete deletion of DG
from mature naı¨ve T cells, we studied the role of a-DG in mature
activated T cells in the context of the proliferative response to
allogeneic stimulation as well as the immune response to LCMV
and influenza virus infections. As shown in Figure 5, panel A,
splenic T cells from both DG/Lck-cre mice and control DGf/f
mice displayed equivalent proliferation in response to allogeneic
splenocytes, depleted of T cells, from Balb/c (H-2d) mice. To
determine the T cell response of DG null mice to LCMV infection,
DG/Lck-cre mice and littermate controls were challenged
intraperitoneally (i.p.) with high (16105 pfu) and low
(56102 pfu) doses of LCMV and then analyzed for T cell
responses at day 8 post-infection, the peak phase of T cell
expansion [23]. The LCMV-specific CD4+ and CD8+ T cells were
detected by MHC-peptide tetramers and intracellular IFN-c
staining (Fig. 5B and 5C). DG/Lck-cre mice showed frequencies of
LCMV-specific CD4+ and CD8+ T cells equivalent to that of
control mice using the CD4 dominant I-Ab-restricted epitope
GP61-80 (IAb/GP61) and the CD8 immunodominant H-2Db-
restricted epitope GP33-41 (Db/GP33) respectively (Fig. 5B and
5C, and Fig. S5). Likewise, determination of cytotoxic activity of
CD8+ T cells by 51Cr-release assay revealed similar levels of killing
by anti-viral CTLs derived from DG/Lck-cre and littermate
control mice (Fig. 5D and Fig. S5). We characterized the anti-viral
CD8+ T cell response to other dominant and subdominant H-
2Db-restricted LCMV epitopes GP276-286, NP205-212, and
NP396-404. Again, there was no apparent difference between
the magnitude and quality of the anti-viral T cell response in DG/
Lck-cre mice compared to control mice during acute LCMV
infection (Fig. S6). Lastly, we examined whether the deletion of
DG can affect the formation of anti-LCMV-specific CD8 memory
T cells. To this end, we challenged LCMV ARM infected mice
with a high dose of the LCMV isolate clone-13 (Cl 13) (26106 pfu)
at 45 d.p.i. and assayed T cell functions 2 days later. DG/Lck-cre
mice exhibited comparable LCMV specific IFN-c expressing
CD4+ and CD8+ T cells to that of littermate controls (Fig. 5E).
Similar to the results we obtained in the acute LCMV infection, no
significant impairment of T cell cytotoxicity was detected in DG/
Lck-cre mice by 51Cr release assay after re-challenge (Fig. 5F and
Fig. S5C), indicating a normal T memory cells response to LCMV
infection in DG/Lck-cre mice.
The distribution of CD4+ T cell subpopulations within DG-L
and DG-L/Lck-cre mice was addressed in order to detect possible
differences in naı¨ve and memory cells in mutant mice. There was
no statistical difference in the distribution of naı¨ve, as well as
CD62L+ and CD62L2 I-AbGP67-77 tetramer+ CD4+ T cells
within the lung, spleen and lymph nodes 45 days post-infection
with LCMV-ARM (data not shown).
We then tested T cell responses of DG null mice to a second
virus infection, i.e., response following intratracheal inoculation
with recombinant influenza/LCMV virus [24]. As shown in
Figure 6, Panel A, the cytotoxicity of pulmonary CD8+ T cells
harvested from the lungs at day 8 post-intratracheal inoculation
with 16105 pfu of influenza virus was equivalent in DG/Lck-cre
Figure 2. T Cell-Specific Deletion of DG in DG/Lck-cre Mice. (A) PCR analysis of dg locus recombination on genomic DNA from sorted DP
thymocytes, splenic B cells, CD4+ and CD8+ T cells, and DCs from DG/Lck-cre mice and littermate controls (DGf/f). Dgf, floxed dg locus. (B) Immunoblot
analysis of DG protein levels from DG/Lck-cre mice and littermate controls. (C) Flow cytometric analysis of functionally glycosylated a-DG in main
subsets of thymocytes from DG/Lck-cre and control (DGf/f) mice. Bold line, anti-glycosylated a-DG; shaded area, unstained. (D) DN thymocytes were
further divided into DN1,4 on the basis of CD44 and CD25 expression and the functionally glycosylated a-DG was analyzed by flow cytometry.
Representative data from one of at least four independent experiments are shown.
doi:10.1371/journal.pone.0009915.g002
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mice when compared to DGf/f littermate controls over several
effector to target ratios. Further, IFN-c production by virus-
specific CD8+ T cells harvested at day 8 post-intratracheal
inoculation from lung, draining mediastinal lymph nodes or
spleen was not significantly different between DG/Lck-cre and
DGf/f mice. This was true when assaying IFN-c responses by ex
vivo peptide stimulation on cells from the lung (Fig. 6B),
mediastinal lymph node (Fig. 6C), and spleen (Fig. 6D) to the
GP33 LCMV immunodominant epitope engineered into the
influenza virus neuraminidase [24] or to the H-2Db immunodo-
minant influenza NP366 epitope. Altogether, our data indicate
that a-DG is dispensable for anti-T cell allogeneic proliferation
and for antiviral-specific T cell effector and memory responses.
Thus in vivo DG does not play a significant role in immunological
synapse between an effector T cell and its target.
In the last series of experiments, considering the role of a-DG as
an ECM receptor implicated in cell migration during the
development of other tissues, e.g. the CNS [25], we addressed
the possible role of a-DG in trafficking of activated T cells. To
address this issue, we induced lethal lymphocytic choriomeningitis
by intracerebral (i.c.) injection of LCMV into the brain of adult
immunocompetent mice [26]. By this means, virus infects the
leptomeninges of the brain and subsequent immunopathologic
injury dependent on the migration of virus-specific cytotoxic CD8+
T cells into the CNS after their activation and proliferation in the
periphery. Upon i.c. infection with LCMV, DG/Lck-cre mice
succumbed to lethal choriomeningitis with the same kinetics as
littermate controls (Fig. S7) and similar robust lymphocyte
infiltration indicating that DG-deficient T cells not only expand
but also migrate normally into the CNS.
Discussion
The present study investigated the role of a-DG during T cell
development and in mature T cells in vivo. Three main points are
made. First, during the development of T cells, the expression of
functionally glycosylated a-DG was differentially regulated with
highest expression levels found on DN thymocytes followed by down-
regulation in DP and CD4+ and CD8+ SP thymocytes. Second,
ablation of DG in DN thymocytes resulted in impaired T cell
development characterized by a marked reduction in cell numbers of
DP and SP thymocytes associated with increased apoptosis. Third,
despite the effect of a-DG on T cell development, a-DG deficient
mature naı¨ve T cells in the periphery showed normal migration,
effector and memory function.
Extensive work over the past two decades has illuminated the
function of DG in muscle, the nervous system, and other organs.
However, the role of this important receptor in the immune
system, in particular T cells, has hardly been addressed and when
so studies were limited to in vitro systems [7]. To assess the role of
DG during T cell development in vivo, we examined the expression
of functionally glycosylated a-DG on different subsets of
Figure 3. T Lymphocyte Developmental Defects in the Adult DG/Lck-cre Mice. (A) DG/Lck-cre mice had smaller thymi compared to the DGf/
f controls. (B) Architecture of the thymus was assessed by hematoxylin and eosin staining on the fixed thymic sections from DG/Lck-cre and DGf/f
mice. Magnification = 56. (C) A representative plot of CD4 vs. CD8 on gated Lin2 thymocytes from DG/Lck-cre and DGf/f is shown (left). Cell numbers
of major thymocyte subsets from adult thymi were calculated after gating of various subsets (right). Numbers are mean 6 SD from 12 mice per
genotype at 6–8 wk of age. *P,0.05 (Student’s two-tailed t test with equal variance). (D) DN subsets were assessed by CD44 and CD25 (left) and
numbers of DN subsets (right) were calculated as in C. (E) Absolute cell numbers of total T cells in spleen (left) and lymph nodes (middle) from DG/
Lck-cre and DGf/f are plotted. Frequency of T cells in peripheral blood is shown as compared to the control mice (right).
doi:10.1371/journal.pone.0009915.g003
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thymocytes using antibodies recognizing the specific sugar epitopes
on a-DG that are implicated in recognition of ECM ligands and in
a laminin binding assay. These studies revealed differential
regulation of a-DG glycosylation during the development of T
cells. Functional a-DG was detectable on early DN thymocytes
with highest expression levels on thymocytes at the DN3 and DN4
stages, a critical point of transition in T cell development during
which thymocytes undergo b-selection. The pattern of a-DG
expression in developing T cells in the thymus of adult mice
reported here varies from the results of a recent study on the
dynamics of a-DG expression in T cells from fetal thymus [27].
These differences may be due to the different developmental stage
of the animals used in the studies, fetal versus adult. In addition,
for their FACS staining, Gong et al. [27] used a monoclonal
antibody to the protein core: mAb 6C1 (mouse IgG) directed
against amino acids 572–602 of human dystroglycan, whereas our
studies employed mAb IIH6 (mouse IgM), which specifically
recognized functionally glycosylated a-DG.
The differential expression of glycosylated a-DG during the
transition between DN1 and DN4 T cell precursors correlated
with a marked induction in gene expression of three known and
putative gylcosyltransferases implicated in post-translational mod-
ification of a-DG, namely POMT1, LARGE1, and LARGE2.
Consistent with the expression pattern of functional a-DG on T
cells, ablation of the DG core protein in DN thymocytes by Cre-
LoxP methodology resulted in perturbation of normal T cell
development. When compared to littermate controls, mice bearing
a deletion of DG in T cells had significantly reduced numbers in
DP as well as CD4+ SP thymocytes. Using BrdU incorporation
assays, we found no evidence for significant alterations in cell
proliferation. However, detection of Annexin V and TUNEL
staining revealed increased apoptosis of CD4 and CD8 SP
thymocytes in mice lacking DG in T cells. Apoptosis in DP cells
could not be addressed due to the inherently high turnover of this
cell population. Our in vivo findings complement recent results
employing re-aggregate thymus organ culture (RTOC) to
demonstrate that ablation of DG in T cells in vitro enhanced the
apoptosis rate in DP and SP thymocytes [27].
The morphological changes and marked reduction of thymo-
cyte numbers observed in our DG/Lck-cre mice are reminiscent of
the phenotype in the thymus of (dy/dy) and (dy3k/dy3k) mice that
bear a genetic defect in the laminin a2 chain, a major high affinity
ligand of a-DG. Like DG/Lck-cre mice, (dy/dy) and (dy3k/dy3k)
mice show thymic atrophy of the outer cortex, with a marked
reduction in DP cells associated with increased apoptosis [16,28].
Interestingly, laminin isoforms containing the laminin a2 chain,
laminin-2 and laminin-4, are enriched in the ECM associated with
thymic epithelial cells (TEC) of the subcapsular region where DN3
cells undergo b-selection [16,17]. The similarities between the
perturbation of T cell development observed in our DG/Lck-cre
mice with the defect present in mice lacking functional laminin a2
chain, together with the up-regulation of functional a-DG on DN3
Figure 4. Unaffected Cell Cycle Progression but Increased Cell Death in DG/Lck-cre Mice. (A) Normal cell cycle profile in DN3, DN4, and DP
thymocytes from adult thymi. Mice were inoculated with 1 mg/ml BrdU intraperitoneally 2 h before the thymus was harvested. Thymocytes were
stained with the antibodies described in Materials and Methods to define thymocyte subsets. Cell cycle was analyzed by the staining with anti-BrdU
antibody and 7AAD. Representative plots of BrdU vs 7AAD on gated DN3, DN4, and DP thymocytes are shown (left). Percentage of BrdU+ cells among
DN3, DN4, and DP thymocytes are graphed (right). Data were derived from 4 mice of each genotype. (B) Apoptosis of thymocytes was analyzed by
the staining with annexin V and 7AAD. Representative histograms of annexin V in various thymocyte subsets are shown (left). The percentages of
annexin V+ cells in each subset are displayed. Representative data from one of at least four independent experiments are shown. Mean 6 SD from 6
mice of each genotype. (C) In situ staining of apoptotic cells by TUNEL assay on the frozen thymus section. Images were taken at 56magnification (C)
and reconstructed (D) using MosaiX software.
doi:10.1371/journal.pone.0009915.g004
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and DN4 thymocytes strongly suggests that this receptor-ligand
system contributes to survival of thymocytes that undergo b-
selection. A role of DG in anti-apoptotic signaling is further
suggested by studies in muscle cells in which blocking of laminin-a-
DG binding perturbed signaling through the PI3K/Akt pathway
results in increased apoptosis [29]. We are currently evaluating if a
similar conserved mechanism exists for DG-mediated anti-
apoptotic signaling in muscle and developing T cells.
While the perturbation of normal T cell development upon
ablation of DG occurs in DN thymocytes, mature T cells in the
periphery of DG/Lck-cre mice, although reduced in numbers and
lacking DG, nevertheless exhibited normal T cell functions in the
context of allogeneic proliferation and acute LCMV and influenza
virus infections. Similar virus titers in serum were observed during
LCMV infection in DG/Lck-cre mice and littermate controls and
the numbers of functional anti-viral T cells by lytic assays,
intracellular cytokines, migration, biologic activity in the CNS,
and generation of T cell memory were comparable after
intraperitoneal or intracerebral inoculations. Correspondingly,
acute influenza virus infection initiated via the airways resulted in
equivalent CD8+ CTL activity in lungs of DG/Lck-cre and control
DGf/f littermates. Further, by quantitative FACS analysis and
intracellular staining for IFN-c, equivalent numbers of virus-
specific CD8+ T cells were found in lung, mediastinal lymph nodes
and spleens of influenza virus-infected DG/Lck-cre and DGf/f
mice mirroring the normal migration and effector function of these
cells following respiratory infection [24]. Thus, the overall normal
magnitude and quality of the anti-viral T cell response in DG/
Figure 5. DG/Lck-cre Mice Show T Cell Responses Equivalent to Those of DGf/f Control Littermates During Allogeneic Stimulation
or Acute LCMV Infection. (A) Splenic T cells were isolated from C57BL/6 (H-2b) DG/Lck-cre mice and littermate controls (DGf/f) and labeled with
CFSE prior to co-culture with T cell-depleted splenocytes from Balb/c (H-2d) mice. Proliferating T cells (diluted CFSE) were assessed after staining with
surface marker by flow cytometry analysis. The frequencies of proliferating T cells were quantified. (B–D) In Panels B, C and D, DG/Lck-cre mice and
littermate controls (DGf/f) were inoculated intraperitoneally with LCMV ARM 16105 pfu. Eight days later, splenocytes were harvested and analyzed.
(B) Panel B shows numbers of LCMV-specific T cells as determined by MHC tetramer staining. Representative data of Db/GP33 (immunodominant
virus-specific CD8+ T cell epitope) and IAb/GP61 (immunodominant virus-specific CD4
+ T cell epitope) are shown. (C) Panel C displays intracellular
expression of IFN-c after stimulation of splenocytes for 5 h with peptides GP33 and GP61 specific for CD8+ and CD4+ T cells respectively.
Representative data from one of at least five independent experiments all with similar results. (D) Cytotoxic activity of virus-specific T cells assessed by
51Cr release assay. Specific lysis at varying effector to target cell ratios is shown. Values indicate the percentage of specific 51Cr releasing from target
cells. The data represent the average and standard deviation for four mice per group. (E–F) DG/Lck-cre mice form virus specific CD8+ and CD4+
memory T cells after LCMV infection. DG/Lck-cre and DGf/f C57BL/6 mice were initially infected intraperitoneally with 16105 pfu of LCMV ARM. All
mice cleared infectious virus by 15 days and at 45 days post-virus inoculation were challenged intravenously with 26106 pfu of LCMV Cl 13 to induce
memory T cells [23,30]. Spleen cells were isolated two days after Cl 13 infection. (E) In Panel E LCMV-specific T cells were determined by intracellular
staining of IFN-c producing T cells after stimulating with peptides GP33 and GP61 for 5 h, (F) while in Panel F T cell effector function was detected by
51Cr release assay.
doi:10.1371/journal.pone.0009915.g005
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Lck-cre mice and the migration pattern of such cells indicates that
DG is dispensable for the normal expansion and effector function
of virus-specific T cells. Further, DG was not required for
formation and function of antiviral memory T cells. The lack of a
phenotype despite the reduced numbers of T cells in the periphery
of DG/Lck-cre mice is compatible with earlier studies that
documented clearance of LCMV infection requires ,350,000
virus specific CD8+ and 7,000 CD4+ T cells [30] and that
diminished thymic input of T cells has a minimal impact on the
control of LCMV infection [31].
The lack of functional impairment or migration of DG-deficient
T cells in our in vivo studies using LCMV and influenza virus
stands in contrast to earlier studies using in vitro co-culture systems
that suggested a role of DG on T cells in the formation of
functional immunological synapses between T cells and antigen-
presenting cells [7,22]. The reasons for this discrepancy are
unclear but may be related to differences in the more complex in
vivo infection model that allows for more functional redundancy
and is biologically more relevant. Although our studies have not
yet uncovered any overt functional defects in mature T cells
lacking DG, we can at this point not categorically exclude the
existence of compensatory mechanisms, e.g. changes in the
selected TCR repertoire that may compensate for impaired
thymocyte signaling and survival.
Materials and Methods
Mice
All animals were handled in strict accordance with good animal
practice as defined by the requirement of the National Institute of
Health and The Scripps Research Institute animal committee, and
all animal work was approved by the The Scripps Research
Institute animal committee. C57BL/6 or Balb/ByJ mice were
bred and maintained in a closed breeding facility at the Scripps
Research Institute. C57BL/6 mice bearing floxed DG alleles have
been described [25]. DG/Lck-cre mice were generated by crossing
the mice carrying LoxP-flanked (floxed) DG gene with Lck-cre
transgenic mice (the Jackson Laboratory) [19].
Figure 6. DG Null (DG/Lck-cre) Mice and Control (DGf/f) Mice Generate Equivalent Functional Virus-Specific CD8+ T Cell Responses
After Challenge with Influenza Virus. DG/Lck-cre mice and littermate controls (DGf/f) were inoculated intratracheally with 16105 pfu of
recombinant influenza virus that also expressed the immunodominant Db LCMV CD8 epitope GP33. The normal influenza immunodominant epitope
is NP366. (A) Eight days post-infection, the cytotoxicity of pulmonary CD8+ T cells was assessed by 51Cr release by NP366 peptide-pulsed target cells.
Lungs from five mice were pooled per group. Virus-specific CD8+ T cells from lung (B), draining mediastinal lymph node (C) and spleen (D) were
detected in mice 8 days post-infection by intracellular staining for IFN-c following a 5 h incubation in the presence of indicated peptides. There was
no statistical difference among T cell functions of DG/Lck-cre mice or DGf/f littermate controls in any of the various tissue compartments. Four to five
mice used per group.
doi:10.1371/journal.pone.0009915.g006
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Genomic PCR to Detect DG Deletion
Genomic DNA from total thymocytes or sorted cells from
thymus or spleen were isolated and subjected to PCR using
specific primers [25] to detect the floxed and deleted DG allele.
OCT2 was used as control for DNA input in PCR.
Mononuclear Cell Isolation and Tissue Processing
The spleen, thymus, lung, and combined cervical and
mediastinal lymph nodes were harvested from mice and
mechanically disrupted through a 70-mm strainer. After treated
with RBC lysis buffer (0.14 M NH4Cl in HEPES, pH 7.0), cells
were washed with PBS and resuspended with complete medium
(RPMI 1640 supplemented with 10% FBS, penicillin- streptomy-
cin, HEPES, non-essential amino acid, L-glutamine, sodium
pyruvate, and b-mercaptoethanol) for culture or with FACS
staining buffer (2% FBS in PBS) for staining.
Flow Cytometry and Cell Sorting
The following antibodies were purchased from either
eBioscience or BD Biosciences: FITC conjugated CD3, CD4,
CD44, and TNF-a antibodies, PE conjugated cdTCR, c-kit,
CD19, NK1.1, and mouse-IgM antibodies, PerCP-Cy5.5 conju-
gated NK1.1 and CD19 antibodies, APC conjugated CD25 and
IFN-c antibodies, PE-Cy7 conjugated CD4, and Pacific Blue
conjugated CD8. Cells isolated from tissue were stained for 1 h at
room temperature with I-AbGP67-77 tetramers (NIH tetramer
core) to assess LCMV-specific CD4+ T cells. For intracellular
staining, cells stained with surface proteins were fixed with 4%
paraformaldehyde and permeabilized with saponin buffer (0.1%
saponin in FACS staining buffer). Antibodies for intracellular
staining were diluted and incubated with cells in the saponin
buffer. Stained cells were analyzed on a LSRII flow cytometer (BD
Biosciences) using DIVA software and the data were analyzed
using FlowJo software (Tree Star). To sort thymocytes, non-T cell
lineage cells were excluded using a mixture of PE-conjugated
CD19, NK1.1, and TCRcd antibodies. When DN subsets were
desired, DP and SP thymocytes were depleted using PE-
conjugated CD4 and CD8 antibodies followed by Sheep anti-
Rat Dynabeads. Specific cell subsets defined by their cell surface
markers were sorted by ARIA cell sorter (BD Biosciences). Sorted
cells were typically .98% pure.
cDNA synthesis and real-time PCR assay. Total RNA
was extracted from cells using the RNeasy isolation kit (Qiagen).
First-strand complementary DNA (cDNA) was synthesized from
total RNA using the AMV reverse transcriptase (Roche),
according to the manufacturer’s instructions, and a 1:1 mix of
primer random p(dN)6 (Roche) and oligo d(T) 16 (Applied
Biosystems). Each of the target genes were real-time amplified
from cDNA using oligonucleotides specific to each gene (sequences
and conditions available upon request), and Rps29 was used as the
normalization control. The cDNA levels were determined using
SYBR green in a MyiQ rt-PCR detection system (BioRad). All
samples were run in triplicate.
Cell Death and Proliferation Assay
Annexin-V and 7-AAD staining (BD Biosciences) were used to
detect cell death and apoptosis followed by flow cytometric
analysis. For in vivo proliferation, mice were injected with 1 mg of
bromodeoxyuridine (BrdU, BD Biosciences) intraperitoneally.
Two hours later, thymi were harvested and stained with selected
antibodies followed by flow cytometric analysis. Cell cycle analysis
was performed by a BrdU-FITC kit (BD Biosciences) following the
manufacturer’s instructions.
TUNEL Assay
To detect apoptosis in situ, thymi were harvested and submerged
in OCT (Tissue-Tek) and frozen on dry ice. Frozen thymi were cut
in 6-mm sections and fixed with 1% paraformaldehyde. The TdT-
mediated dUTP nick-end labeling (TUNEL) assay was performed
using ApopTag Red kit (Millipore, Billerica, MA) following the
manufacturer’s protocol. All sections were costained with 1 mg/ml
DAPI (Sigma-Aldrich) for 5 min at room temperature to visualize
cell nuclei. The image of each field on the section was captured
using an immunofluorescence microscope (Axiovert S100, Carl
Zeiss MicroImaging, Inc.) with an automated xy stage, a color
digital camera (Axiocam, Carl Zeiss MicroImaging, Inc.) and a 56
objective. Reconstructions were performed using the MosaiX
function in KS300 image analysis software (Carl Zeiss MicroIma-
ging, Inc.).
Immunoblotting and Laminin Overlay Assay
Immunoblotting was performed as described [32]. In brief,
sorted thymocytes were lysed in SDS-PAGE sample buffer and
subjected to SDS-polyacrylamide gel electrophoresis. After
transfer to a nitrocellulose membrane, membranes were blocked
in 5% (wt/vol) skim milk in phosphate-buffered saline (PBS) and
incubated with monoclonal antibody 8D5 to b-DG (Novocastra)
and a polyclonal rabbit anti-actin antibody (ST Cruz Biotechnol-
ogy). Secondary antibodies to mouse and rabbit IgG (Pierce)
coupled to horse radish peroxidase (HRP) were applied 1:5,000 in
PBS-0.1% (wt/vol) Tween 20 for 1 h at room temperature. Blots
were developed by enhanced chemiluminescence (ECL) using
Super Signal West Pico ECL substrate (Pierce). Laminin overlay
assay (LOA) was performed as described [33].
Virus and Infection
LCMV Armstrong clone 53b (ARM) and Clone 13 (Cl 13)
were plaque-purified three times on Vero cells and stocks
prepared by a single passage on BHK-21 cells [34]. Viral titers
were determined by plaque formation on Vero cells [34]. Mice at
the age of 6–8 weeks were injected intraperitoneal (i.p.) with
16105 or 56102 plaque-forming units (pfu). For the rechallenge
experiments, mice were infected intravenously (i.v.) with
26106 pfu of LCMV Cl 13. For lethal choriomeningitis, mice
were inoculated with 103 pfu of LCMV ARM intracranially (i.c.).
For determination of LCMV-specific CD4+ T cell memory, mice
were infected with 26106 PFU LCMV-ARM i.v. Influenza virus
(A/WSN/33; H1N1) recombinant expressing the LCMV H-2b
immunodominant CD8 and CD4 T cell epitopes engineered into
the influenza neuraminidase stalk was used as described [24].
Briefly, DG/Lck-cre mice and littermate controls (DGf/f) were
inoculated intratracheally with the influenza recombinant virus
using 16105 pfu. After 8 days of infection, the cytotoxicity of T
cells was assessed by 51Cr-release assay while viral-specific CD8
and CD4 T cells were detected by incubation with various
peptides as indicated below.
Cytotoxicity (CTL) Assay
Virus-specific CTL lysis was quantitated with a 51Cr-release
assay as described [35]. In brief, splenocytes from LCMV ARM or
splenocytes, lymph node and pulmonary cells from recombinant
influenza virus infected mice at 8 d.p.i. were obtained. For
LCMV, BALB Cl 7 (H-2d) and MC57 (H-2b) target cells infected
with LCMV were labeled with 51Cr. E/T ratios of 50:1, 25:1,
12.5:1, and 6.3:1 were used. For influenza virus, 51Cr labeled
MC57 cells target cells were loaded with influenza virus peptide
NP366 (ASNENMDAM) for 1 hr at 37uC. After 5 h incubation,
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cell supernatant was collected and quantitated by a 20/20 series c-
counter. All samples were run in triplicate, and results were
calculated as: 1006 (experimental release-spontaneous release)/
(maximum release-spontaneous release).
T Cell Assay
For intracellular cytokine analysis of LCMV-infected mice, T cells
were isolated after 8 days post infection and stimulated for 5 hours
with 5 mg/ml of the MHC class II-restricted LCMV-GP61-80
peptide or 2 mg/ml of individual MHC class I-restricted LCMV-
GP33–41, LCMV-GP276–286, LCMV-NP396–404, LCMV-
NP205–212 peptides (all.99% pure; Synpep Corp.) in the presence
of 50 U/ml recombinant IL-2 (R&D systems) and 1 mg/ml brefeldin
A (Sigma-Aldrich). For tetramer staining, DbGP33 (MHC class I) and
I-AbGP61 (MHC class II) tetramers were used at a 1:50–1:100
dilution in FACS buffer. For analysis of CD8+ T cell intracellular
cytokine expression, cells form lung, mediastinal lymph node, and
spleen were incubated with 2 mg/ml of individual MHC class I-
restricted LCMV-GP33–41 or influenza virus-NP366 in the presence
of 50 U/ml recombinant IL-2 (R&D systems) and 1 mg/ml brefeldin
A (Sigma-Aldrich) for 5 hr at 37uC.
Mixed Leukocyte Reaction
Naı¨ve splenocytes were harvested from DGf/f and DG/Lck-cre
mice (H-2b). T cells were purified using the EasySepH T Cell
Enrichment Kit (Stemcell Technologies Inc.). Purified T cells were
labeled with CFSE (Invitrogen) to monitor proliferation. Antigen-
presenting cells (APC) were purified from Balb/c splenocytes (H-
2d) using the EasySepH Mouse CD90 Positive Selection Kit
(Stemcell Technologies Inc.). DGf/f and DG/Lck-cre T cells
labeled with CFSE were co-cultured with Balb/c APC in a 96-well
U-bottom plate at a ratio of 4:1 (26105 Balb/c APC: 56104 T
cells). Cultures were placed at 37uC at 5% CO2 for 5 days. Cell
proliferation was analyzed by flow cytometry assessing dilution of
CFSE within total T cells.
Supporting Information
Figure S1 Resting T cell express core but not functionally
glycosylated a-DG. Splenocytes were isolated from C57BL/6 mice
and analyzed by flow cytometry. Glycosylated a-DG and the core
a-DG were detected with monoclonal antibodies and shown on
gated CD3+ T cells. Bold line, anti-glycosylated or core a-DG as
indicated; shaded area, isotype control.
Found at: doi:10.1371/journal.pone.0009915.s001 (0.55 MB TIF)
Figure S2 Ablation of DG gene in DG/Lck-cre mice during T
cell development. PCR were performed on genomic DNA for
sorted thymocyte subsets from DG/Lck-cre mice for recombined
DG locus (dgD) and OCT2 (control).
Found at: doi:10.1371/journal.pone.0009915.s002 (0.34 MB TIF)
Figure S3 Both Lck-cre and control mice show comparable
numbers of thymocytes. Thymocytes were harvested from DGf/f
(littermate control), Lck-cre, and DG/Lck-cre mice, then stained
with specific antibodies as described in the Materials and Methods
followed by flow cytometric analysis. Cell numbers were calculated
from the total thymocytes versus the frequency of each thymocyte
subset.
Found at: doi:10.1371/journal.pone.0009915.s003 (0.20 MB TIF)
Figure S4 DG/Lck-cre mice and littermate control (DGf/f)
mice express comparable TCR Vb repertoire in splenic T cells.
Splenocytes from DG/Lck-cre and DGf/f mice were stained with
antibodies to surface markers and TCR Vb chain and subjected to
flow cytometric analysis. The percentage of TCR Vb-positive cells
was analyzed by gating on CD4+ and CD8+ T cells.
Found at: doi:10.1371/journal.pone.0009915.s004 (0.43 MB TIF)
Figure S5 Both DG/Lck-cre mice and DG sufficient (DGf/f)
mice generate functional virus specific T cell responses after
challenged with low dose of LCMV ARM. DG/Lck-cre mice and
littermate controls (DGf/f) were inoculated with LCMV-ARM
56102 pfu intraperitoneally. A. After 8 days of infection, viral
specific CD8+ and CD4+ T cells were detected by incubation with
peptides GP33 and GP61 respectively. IFN-c expressing cells were
detected by intracellular staining. B. Detection of memory T cell
response after 2 days of challenging with LCMV-Cl 13. C. The
cytotoxicity of T cells was assessed by 51Cr releasing assay. See
materials and methods for details.
Found at: doi:10.1371/journal.pone.0009915.s005 (3.30 MB TIF)
Figure S6 LCMV infection generates virus specific CD8 T cell
responses to both dominant and sub-dominant epitopes in DG/
Lck-cre and control (DGf/f) mice. Splenocytes were isolated and
stimulated with various dominant and sub-dominant LCMV-
specific peptides for 5 hours as described in materials and
methods. Intracellular staining to IFN-c was performed to reveal
LCMV specific CD8+ T cells. Representative data are shown
from one of three independent experiments with at least four mice
for each genotype.
Found at: doi:10.1371/journal.pone.0009915.s006 (6.71 MB TIF)
Figure S7 DG/Lck-cre mice and control DGf/f littermates
show comparable kinetics in developing LCMV induced menin-
gitis. DG/Lck-cre mice and littermate controls (DGf/f) were
inoculated with LCMV ARM 16103 pfu intracranially and the
survival rates of infected mice were plotted. Representative data
are derived from 6 mice per genotype.
Found at: doi:10.1371/journal.pone.0009915.s007 (1.40 MB TIF)
Acknowledgments
This is publication No. 20034 from the Department of Immunology and
Microbial Science at The Scripps Research Institute, La Jolla, CA. We
thank Nathan Lee, Melanie Das, and Hanna Lewicki for technical support,
and Dr. Lucile Garidou and Dr. David Brooks for suggestions and
discussions.
Author Contributions
Conceived and designed the experiments: LYL KBW KPC MBAO SK.
Performed the experiments: LYL KBW ARV DBVdB MW. Analyzed the
data: LYL KBW DBVdB KPC MBAO SK. Contributed reagents/
materials/analysis tools: KPC. Wrote the paper: LYL KBW KPC MBAO
SK.
References
1. Barresi R, Campbell KP (2006) Dystroglycan: from biosynthesis to pathogenesis
of human disease. J Cell Sci 119: 199–207.
2. Henry MD, Campbell KP (1998) A role for dystroglycan in basement membrane
assembly. Cell 95: 859–870.
3. Henry MD, Satz JS, Brakebusch C, Costell M, Gustafsson E, et al. (2001)
Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface
laminin organization. J Cell Sci 114: 1137–1144.
4. Cohn RD (2005) Dystroglycan: important player in skeletal muscle and beyond.
Neuromuscul Disord 15: 207–217.
5. Kanagawa M, Toda T (2006) The genetic and molecular basis of muscular dystrophy:
roles of cell-matrix linkage in the pathogenesis. J Hum Genet 51: 915–926.
6. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P (1998)
Distribution of dystroglycan in normal adult mouse tissues. J Histochem
Cytochem 46: 449–457.
Dystroglycan in T Cells
PLoS ONE | www.plosone.org 10 March 2010 | Volume 5 | Issue 3 | e9915
7. Zhang J, Wang Y, Chu Y, Su L, Gong Y, et al. (2006) Agrin is involved in
lymphocytes activation that is mediated by alpha-dystroglycan. Faseb J 20:
50–58.
8. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MBA (2001)
Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-
dystroglycan. J Cell Biol 155: 301–310.
9. Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, et al. (2000)
Immunosuppression and resultant viral persistence by specific viral targeting
of dendritic cells. J Exp Med 192: 1249–1260.
10. Takahama Y (2006) Journey through the thymus: stromal guides for T-cell
development and selection. Nat Rev Immunol 6: 127–135.
11. Bhandoola A, Sambandam A (2006) From stem cell to T cell: one route or
many? Nat Rev Immunol 6: 117–126.
12. Ciofani M, Zuniga-Pflucker JC (2007) The thymus as an inductive site for T
lymphopoiesis. Annu Rev Cell Dev Biol 23: 463–493.
13. Germain RN (2002) T-cell development and the CD4-CD8 lineage decision.
Nat Rev Immunol 2: 309–322.
14. Rothenberg EV (2007) Cell lineage regulators in B and T cell development. Nat
Immunol 8: 441–444.
15. Rothenberg EV (2007) Negotiation of the T lineage fate decision by
transcription-factor interplay and microenvironmental signals. Immunity 26:
690–702.
16. Magner WJ, Chang AC, Owens J, Hong MJ, Brooks A, et al. (2000) Aberrant
development of thymocytes in mice lacking laminin-2. Dev Immunol 7:
179–193.
17. Kutlesa S, Siler U, Speiser A, Wessels JT, Virtanen I, et al. (2002)
Developmentally regulated interactions of human thymocytes with different
laminin isoforms. Immunology 105: 407–418.
18. Ervasti JM, Campbell KP (1991) Membrane organization of the dystrophin-
glycoprotein complex. Cell 66: 1121–1131.
19. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K (1994) Deletion of a
DNA polymerase beta gene segment in T cells using cell type-specific gene
targeting. Science 265: 103–106.
20. Wolfer A, Wilson A, Nemir M, MacDonald HR, Radtke F (2002) Inactivation of
Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent
survival of early alpha beta Lineage Thymocytes. Immunity 16: 869–879.
21. Kappler JW, Roehm N, Marrack P (1987) T cell tolerance by clonal elimination
in the thymus. Cell 49: 273–280.
22. Khan AA, Bose C, Yam LS, Soloski MJ, Rupp F (2001) Physiological regulation
of the immunological synapse by agrin. Science 292: 1681–1686.
23. Homann D, Teyton L, Oldstone MB (2001) Differential regulation of antiviral
T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat
Med 7: 913–919.
24. Marsolais D, Hahm B, Walsh KB, Edelmann KH, McGavern DB, et al. (2009)
A critical role for the sphingosine analog AAL-R in dampening the cytokine
response during influenza virus infection. Proc Natl Acad Sci USA 105:
1560–1565.
25. Moore SA, Saito F, Chen J, Michele DE, Henry MD, et al. (2002) Deletion of
brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
Nature 418: 422–425.
26. McGavern DB, Christen U, Oldstone MB (2002) Molecular anatomy of antigen-
specific CD8(+) T cell engagement and synapse formation in vivo. Nat Immunol
3: 918–925.
27. Gong Y, Zhang R, Zhang J, Xu L, Zhang F, et al. (2008) Alpha-dystroglycan is
involved in positive selection of thymocytes by participating in immunological
synapse formation. Faseb J 22: 1426–1439.
28. Iwao M, Fukada S, Harada T, Tsujikawa K, Yagita H, et al. (2000) Interaction
of merosin (laminin 2) with very late activation antigen-6 is necessary for the
survival of CD4+ CD8+ immature thymocytes. Immunology 99: 481–488.
29. Langenbach KJ, Rando TA (2002) Inhibition of dystroglycan binding to laminin
disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle
Nerve 26: 644–653.
30. Berger DP, Homann D, Oldstone MBA (2000) Defining parameters for
successful immunocytotherapy of persistent viral infection. Virology 266:
257–263.
31. Miller NE, Bonczyk JR, Nakayama Y, Suresh M (2005) Role of thymic output in
regulating CD8 T-cell homeostasis during acute and chronic viral infection.
J Virol 79: 9419–9429.
32. Kunz S, Rojek JM, Kanagawa M, Spiropoulou CF, Barresi R, et al. (2005)
Posttranslational modification of alpha-dystroglycan, the cellular receptor for
arenaviruses, by the glycosyltransferase LARGE is critical for virus binding.
J Virol 79: 14282–14296.
33. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, et al. (2002) Post-
translational disruption of dystroglycan-ligand interactions in congenital
muscular dystrophies. Nature 418: 417–422.
34. Dutko FJ, Oldstone MBA (1983) Genomic and biological variation among
commonly used lymphocytic choriomeningitis virus strains. J Gen Virol 64:
1689–1698.
35. Borrow P, Tishon A, Oldstone MB (1991) Infection of lymphocytes by a virus
that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
J Exp Med 174: 203–212.
Dystroglycan in T Cells
PLoS ONE | www.plosone.org 11 March 2010 | Volume 5 | Issue 3 | e9915
